MilliporeSigma
  • Home
  • Search Results
  • Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.

Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.

International journal of nanomedicine (2014-08-22)
Wesley Nyaigoti Omwoyo, Bernhards Ogutu, Florence Oloo, Hulda Swai, Lonji Kalombo, Paula Melariri, Geoffrey Maroa Mahanga, Jeremiah Waweru Gathirwa
ABSTRACT

Primaquine (PQ) is one of the most widely used antimalarial drugs and is the only available drug that combats the relapsing form of malaria. PQ use in higher doses is limited by severe tissue toxicity including hematological- and gastrointestinal-related side effects. Nanoformulation of drugs in an appropriate drug carrier system has been extensively studied and shown to have the potential to improve bioavailability, thereby enhancing activity, reducing dose frequency, and subsequently reducing toxicity. The aim of this work was to design, synthesize, and characterize PQ-loaded solid lipid nanoparticles (SLNs) (PQ-SLNs) as a potential drug-delivery system. SLNs were prepared by a modified solvent emulsification evaporation method based on a water-in-oil-in-water (w/o/w) double emulsion. The mean particle size, zeta potential, drug loading, and encapsulation efficiency of the PQ-SLNs were 236 nm, +23 mV, 14%, and 75%, respectively. The zeta potential of the SLNs changed dramatically, from -6.54 mV to +23.0 mV, by binding positively charged chitosan as surface modifier. A spherical morphology of PQ-SLNs was seen by scanning electron microscope. In vitro, release profile depicted a steady drug release over 72 hours. Differential scanning calorimeter thermograms demonstrated presence of drug in drug-loaded nanoparticles along with disappearance of decomposition exotherms, suggesting increased physical stability of drug in prepared formulations. Negligible changes in characteristic peaks of drug in Fourier transform infrared spectra indicated absence of any interaction among the various components entrapped in the nanoparticle formulation. The nanoformulated PQ was 20% more effective as compared with conventional oral dose when tested in Plasmodium berghei-infected Swiss albino mice. This study demonstrated an efficient method of forming a nanomedicine delivery system for antimalarial drugs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethyl acetate, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Ethyl acetate, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
Ethyl acetate, suitable for HPLC, ≥99.8%
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Lactose (Monohydrate), Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Stearic acid, certified reference material, TraceCERT®
Sigma-Aldrich
Ethyl acetate, anhydrous, 99.8%
Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
Ethyl acetate, ≥99%, FCC, FG
Sigma-Aldrich
Ethyl acetate, natural, ≥99%, FCC, FG
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Ethyl acetate, ACS reagent, ≥99.5%
Supelco
Ethyl acetate, HPLC grade, 99.8%
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Ethyl acetate, ReagentPlus®, ≥99.8%
Supelco
Stearic acid, analytical standard
Supelco
Ethyl acetate, analytical standard
Sigma-Aldrich
Ethyl acetate, ACS reagent, ≥99.5%
Stearic acid, European Pharmacopoeia (EP) Reference Standard
USP
Lactose monohydrate, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethyl acetate, biotech. grade, ≥99.8%
Sigma-Aldrich
Ethyl acetate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
Ethyl acetate, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99.5% (GC)
Sigma-Aldrich
Ethyl acetate, ACS reagent, ≥99.5%
Supelco
Ethyl Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ethyl acetate
Sigma-Aldrich
Ethyl acetate
USP
Stearic acid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-Lactose monohydrate, ACS reagent
Sigma-Aldrich
D-Lactose monohydrate, tested according to Ph. Eur.